Sharck Soup Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Sharck Soup

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (29288)	6/23/2001 11:25:36 AM
From: Sharck	Read Replies (1) of 37746

Hi George, "...he market thinks will gain approval..." But what leads you to believe they won't both get approval, or are they working on some joint projects? "XOMA has more things in the pipeline than most realize including potential new partnerships...." Right, but I thought one of those partnerships was with Biogen. The Baxter partnership is not well understood as much of it is still confidential. Clinical trials for crohn's begin sometime in July, if things go as XOMA has said. Again, I agree on what you say, have no problem shorting BGEN and playing XOMA on momo. If you read my opening remarks on Friday, you will notice a post that mentioned $ flows was coming out of the bios and into fiber optics. Taking a look at some recent high fliers in this sector, I would not be surprised to see further downside including BGEN: finance.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next